Logo image of VNDA

VANDA PHARMACEUTICALS INC (VNDA) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:VNDA - US9216591084 - Common Stock

5 USD
+0.11 (+2.25%)
Last: 11/25/2025, 8:17:21 PM
5 USD
0 (0%)
After Hours: 11/25/2025, 8:17:21 PM
Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to VNDA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 11.99. This target is 139.7% above the current price.
VNDA was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about VNDA.
In the previous month the buy percentage consensus was at a similar level.
VNDA was analyzed by 9 analysts. More opinions would make the average more meaningful.
VNDA Historical Analyst RatingsVNDA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -107 -97 -87 -77 -67 -57 -47 -37 -27 -17 -7 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 5.005.0511.2211.9921.00 - 1.00% 124.40% 139.70% 320.00%
VNDA Current Analyst RatingVNDA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2025-11-19 HC Wainwright & Co. Reiterate Buy -> Buy
2025-11-05 B. Riley Securities Initiate Buy
2025-10-30 Cantor Fitzgerald Maintains Overweight -> Overweight
2025-08-21 HC Wainwright & Co. Reiterate Buy -> Buy
2025-05-07 HC Wainwright & Co. Reiterate Buy -> Buy
2025-04-01 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-18 HC Wainwright & Co. Maintains Buy -> Buy
2025-02-04 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-28 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-21 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-23 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-31 HC Wainwright & Co. Initiate Buy
2024-08-01 Cantor Fitzgerald Maintains Overweight -> Overweight
2024-07-11 Cantor Fitzgerald Initiate Overweight
2022-02-25 Jefferies Downgrade Buy -> Hold
2021-05-12 B of A Securities Initiate Buy

VANDA PHARMACEUTICALS INC / VNDA FAQ

What is the average price target for VANDA PHARMACEUTICALS INC (VNDA) stock?

9 analysts have analysed VNDA and the average price target is 11.99 USD. This implies a price increase of 139.7% is expected in the next year compared to the current price of 5.


How do analysts rate VANDA PHARMACEUTICALS INC (VNDA)?

The consensus rating for VANDA PHARMACEUTICALS INC (VNDA) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.


What is the number of analysts for VNDA stock?

The number of analysts covering VANDA PHARMACEUTICALS INC (VNDA) is 9.